Abstract
Cancers of the liver are increasing throughout the world. Cirrhosis, hepatitis B and C, nonalcoholic fatty liver disease, and metastases from cancers of the colon and the breast are some of the largest contributors to liver cancers. Many patients with chronic liver disease develop cirrhosis and then primary liver cancer. Cirrhosis may lead to increased fibrous tissue development and destruction of native liver cells. The exhaustion of the regenerative ability of the liver may contribute to the formation of hepatocellular carcinomas. Diagnosis of liver cancer is most frequently found through computed tomography (CT) and a rise in alpha-fetoprotein (AFP) levels. It may also be incidental to findings of another type of cancer, as in the metastatic form of cancer.
Original language | English (US) |
---|---|
Title of host publication | Oncologic Critical Care |
Publisher | Springer International Publishing |
Pages | 1793-1808 |
Number of pages | 16 |
ISBN (Electronic) | 9783319745886 |
ISBN (Print) | 9783319745879 |
DOIs | |
State | Published - Oct 12 2019 |
Keywords
- Child-Turcotte-Pugh score
- Chronic liver disease
- Cirrhosis
- Hepatectomy
- Hepatocellular carcinoma
- MELD score
- Metastatic liver disease
- Microwave ablation
- Portal vein embolization
- Radiofrequency ablation (RFA)
- Transcatheter arterial chemoembolization (TACE)
ASJC Scopus subject areas
- General Medicine